Two Sigma Advisers
HURA

Two Sigma Advisers’s TuHURA Biosciences HURA Stock Holding History

Two Sigma Advisers’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17
Closed -$15K – 2938
2021
Q4 		$15K Buy
+17
New +$23K ﹤0.01% 2560
2021
Q3 		– Sell
-6
Closed -$23K – 2717
2021
Q2 		$23K Buy
+6
New +$17.2K ﹤0.01% 2407

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Two Sigma Advisers's HURA Position: Q1 2022 in Review

Two Sigma Advisers sold out of TuHURA Biosciences (HURA) in Q1 2022, closing a stake of 17 shares — an estimated $15K sold.

Two Sigma Advisers first reported a position in HURA in Q2 2021 and held it in 2 quarters. The position peaked at $23K in Q2 2021. 22 funds tracked by Wall St. Rank hold HURA as of Q1 2022.

  • Two Sigma Advisers reported no remaining TuHURA Biosciences position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 17 TuHURA Biosciences shares in Q1 2022, an estimated $15K.
  • Two Sigma Advisers first reported a position in TuHURA Biosciences in Q2 2021 and held it in 2 quarters.
  • Two Sigma Advisers's TuHURA Biosciences position peaked at $23K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.